1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Significance of circulating tumor cells in metastatic triple negative breast cancer: Results of an open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 tigatuzumab (TBCRC 019)
    Meeting Abstract

    Paoletti, C.; Li, Y.; Muñiz, M. C.; Kidwell, K. M.; Aung, K.; Thomas, D. G.; Brown, M. E.; Abramson, V.; Irvin, W. J. Jr; Lin, N. U.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Positive predictive value (PPV) of the diagnosis of atypia in breast core biopsies: An audit of MSKCC breast pathology service
    Meeting Abstract

    Conlon, N.; Gallagher, M.; Catalano, J.; Howard, J.; Tan, L. K.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase 2 study of ridaforolimus (RIDA) and dalotuzumab (DALO) in estrogen receptor positive (ER+) breast cancer
    Meeting Abstract

    Baselga, J.; Morales, S. M.; Awada, A.; Blum, J. L.; Tan, A. R.; Ewertz, M.; Cortes, J.; Moy, B.; Ruddy, K. J.; Haddad, T.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • William L. McGuire memorial lecture — Local therapy in the molecular era: Relevant or relic?
    Meeting Abstract

    Morrow, M.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Multicenter phase II trial of the novel compound PM01183 (P) in BRCA1/2-associated or unselected metastatic breast cancer (MBC)
    Meeting Abstract

    Isakoff, S. J.; Cruz, C.; Garber, J.; Lluch, A.; Fidalgo, J. A. P.; Tung, N.; Fernandez, C.; Kahatt, C.; Szyldergemajn, S.; Matos-Pita, A. S.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase I study of the combination of BKM120 and olaparib for the treatment of high grade serous ovarian cancer (HGSC) and triple negative breast cancer (TNBC)
    Meeting Abstract

    Matulonis, U. A.; Wulf, G.; Cantley, L.; Mills, G.; Lasonde, B.; Atkinson, T.; Whalen, C.; Isakoff, S. J.; Westin, S.; Bell-McGuinn, K.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II, randomized, parallel-cohort study of neoadjuvant buparlisib (BKM120) in combination with trastuzumab and paclitaxel in women with HER2-positive, PIK3CA mutant and PIK3CA wild-type primary breast cancer - NeoPHOEBE
    Meeting Abstract

    Loi, S.; Loibl, S.; Di Cosimo, S.; Nekljudova, V.; Flamen, P.; Saini, K. S.; Michiels, S.; de la Pena, L.; Nanni, S.; Urban, P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A randomized phase 2 study of the triplet combination of ridaforolimus (RIDA), dalotuzumab (DALO) and exemestane (EX) compared to the ridaforolimus, exemestane doublet in high proliferation, estrogen receptor positive (ER+) advanced breast cancer
    Meeting Abstract

    Rugo, H. S.; Tredan, O.; Ro, J.; Morales, S. M.; Musolina, A.; Afonso, N.; Ferreira, M.; Park, K. H.; Cortes, J.; Tan, A. R.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Tumor-derived exosomes promote pre-metastatic niche formation and organotropism
    Meeting Abstract

    Lyden, D. C.; Peinado-Selgas, H.; Nitadori, A.; Shen, T. L.; Aleckovic, M.; Kang, Y.; Bromberg, J.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Towards rationale therapy: Dealing with intertumor and intratumor heterogeneity
    Meeting Abstract

    Amir, E. D.; Litvin, O.; Levine, J.; Bendall, S. C.; Davis, K. L.; Simonds, E. F.; Schild, T.; Rocco, M.; Rosen, N.; Nolan, G. P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save